How the lymph node metastases toward cervico-upper mediastinal region affect the outcome of patients with carcinoma of the thoracic esophagus

被引:13
作者
Nakano, S [1 ]
Baba, M [1 ]
Shimada, M [1 ]
Shirao, K [1 ]
Noguchi, Y [1 ]
Kusano, C [1 ]
Natsugoe, S [1 ]
Yoshinaka, H [1 ]
Fukumoto, T [1 ]
Aikou, T [1 ]
机构
[1] Kagoshima Univ, Fac Med, Dept Surg 1, Kagoshima 8900075, Japan
关键词
lymph node metastasis of esophageal carcinoma; extranodal invasion; recurrence after esophagectomy; prognostic factor;
D O I
10.1093/jjco/29.5.248
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of this study was to establish whether the site of lymph node metastasis influences the survival of patients with carcinoma of the thoracic esophagus. Methods: A series of 159 patients with lymph node metastasis who underwent right transthoracic Ro esophagectomy was analyzed retrospectively. Sites of the nodal metastasis were divided into two regions; the neck and/or upper mediastinum above (upward metastasis) and the abdomen and/or lower mediastinum below (downward metastasis) the tracheal carina. Results: Univariate analysis of prognostic factors revealed the tumor location, distant lymphatic metastasis, number of metastatic nodes and upward metastasis influenced survival, but downward metastasis did not. Multivariate analysis showed that the number of metastatic nodes and upward metastasis were also significant prognostic factors. Thirty-one (33.3%) of the 93 patients with, but only 6 (9.1%) without, upward metastasis had recurrences in the neck and/or upper mediastinum (P = 0.0002). Eighteen (60.0%) of the 30 patients with extranodal invasion in the neck and/or upper mediastinum had recurrence in these regions. Conclusions: Nodal metastasis in the neck and/or upper mediastinum was a significant risk factor for prognosis, the same as the number of metastatic nodes.
引用
收藏
页码:248 / 251
页数:4
相关论文
共 16 条
[1]  
[Anonymous], INT UNION CANC UICC
[2]  
Baba M, 1997, J SURG ONCOL, V64, P12, DOI 10.1002/(SICI)1096-9098(199701)64:1<12::AID-JSO3>3.0.CO
[3]  
2-S
[4]   LONG-TERM RESULTS OF SUBTOTAL ESOPHAGECTOMY WITH 3-FIELD LYMPHADENECTOMY FOR CARCINOMA OF THE THORACIC ESOPHAGUS [J].
BABA, M ;
AIKOU, T ;
YOSHINAKA, H ;
NATSUGOE, S ;
FUKUMOTO, T ;
SHIMAZU, H ;
AKAZAWA, K .
ANNALS OF SURGERY, 1994, 219 (03) :310-316
[5]  
DESAI PB, 1992, ESOPHAGUS, V5, P99
[6]   MORTALITY AND MORBIDITY RATES, POSTOPERATIVE COURSE, QUALITY-OF-LIFE, AND PROGNOSIS AFTER EXTENDED RADICAL LYMPHADENECTOMY FOR ESOPHAGEAL CANCER - COMPARISON OF 3-FIELD LYMPHADENECTOMY WITH 2-FIELD LYMPHADENECTOMY [J].
FUJITA, H ;
KAKEGAWA, T ;
YAMANA, H ;
SHIMA, I ;
TOH, Y ;
TOMITA, Y ;
FUJII, T ;
YAMASAKI, K ;
HIGAKI, K ;
NOAKE, T ;
ISHIBASHI, N ;
MIZUTANI, K .
ANNALS OF SURGERY, 1995, 222 (05) :654-662
[7]  
GATZINSKY P, 1985, J THORAC CARDIOV SUR, V89, P71
[8]  
ISONO K, 1991, ONCOLOGY, V48, P411
[9]   EVALUATION OF NECK LYMPH-NODE DISSECTION FOR THORACIC ESOPHAGEAL-CARCINOMA [J].
KATO, H ;
WATANABE, H ;
TACHIMORI, Y ;
IIZUKA, T .
ANNALS OF THORACIC SURGERY, 1991, 51 (06) :931-935
[10]   HOW EXTENSIVE SHOULD LYMPH-NODE DISSECTION BE FOR CANCER OF THE THORACIC ESOPHAGUS [J].
MATSUBARA, T ;
UEDA, M ;
YANAGIDA, O ;
NAKAJIMA, T ;
NISHI, M .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (04) :1073-1078